Skip to main content

Table 3 Values determined at baseline and after 12 weeks of exercise intervention

From: Beneficial effects of physical activity in an HIV-infected woman with lipodystrophy: a case report

Variable

Pre-test

Post-test

Change

Percentage change

Body mass, kg

61.2

64

2.8

4.6

Body mass index, kg/m2

22.21

23.23

1.02

4.6

Circumferences, cm

    

Neck circumference

35

33.7

-1.3

-3.7

Chest circumference

93

91.5

-1.5

-1.6

Waist circumference

82

78.3

-3.7

-4.5

Mid-arm circumference

27

29.4

2.4

8.9

Forearm circumference

23.5

24.4

0.9

3.8

Thigh circumference

50

51.2

1.2

2.4

Calf circumference

33.5

34.2

0.7

2.1

Waist-to-hip ratio (WHR)

0.91

0.87

-0.04

-4.3

Body composition

TSF, mm

116.0

94.5

-21.5

-18.5

CSF, mm

88

69.5

-18.5

-21.0

PSF, mm

28

25

-3

-10.7

Fat, %

24.1

19.7

-4.4

-18.3

Body fat, kg

14.7

12.6

-2.1

-12.5

FFM, kg

46.5

51.4

4.9

12.7

Femur, cm

8.4

8.6

0.2

2.4

Humerus, cm

6.4

6.6

0.2

3.1

Metabolic and immunological values

Triglycerides, mg/dL

142

128

-14

-9.9

Total cholesterol, mg/dL

225

198

-27

-12.0

LDL cholesterol, mg/dL

162

148

-14

-8.6

HDL cholesterol, mg/dL

36

42

6

16.7

HbA1c

6.12

6.06

-0.06

-1.0

Fasting glucose, mg/dL

88

90

2

2.3

Leukocytes, cells/m3

6900

7100

200

2.9

Lymphocytes, cells/m3

2463

2560

97

3.9

Neutrophils, cells/m3

3760

3815

55

1.5

Basophils, cells/m3

82.8

81.4

-1.4

-1.7

Monocytes, cells/m3

448.5

455

6.5

1.4

Platelets, cells/m3

279,000

278,600

-400

-0.1

  1. CSF: subcutaneous fat; HbA1c: glycated fasting hemoglobin; PSF: peripheral subcutaneous fat; TSF: total subcutaneous fat